The potential role of m6A modifications on immune cells and immunotherapy

Linchuan Gan1, Yuxiang Zhao1, Yajuan Fu1

  • 1Fujian Key Laboratory of Innate Immune Biology, Biomedical Research Center of South China, College of Life Science, Fujian Normal University Qishan Campus, College Town, Fuzhou, Fujian Province 350117, PR China.

Insights

N6-methyladenosine (m6A) RNA modifications are crucial for immune cell balance and cancer development. Understanding m6A

Area of Science:

  • Molecular Biology
  • Epigenetics
  • Immunology

Background:

  • N6-methyladenosine (m6A) is the most common RNA modification in mammals.
  • m6A dysregulation affects RNA processing, immune homeostasis, and tumor progression.

Purpose of the Study:

  • To summarize m6A's role in immune cell anti-tumor and self-homeostasis.
  • To explore how tumor-intrinsic m6A affects the tumor microenvironment.
  • To discuss m6A inhibitors for cancer therapy.

Main Methods:

  • Literature review and synthesis of current research on m6A modifications.
  • Analysis of m6A's impact on immune cell function and tumor development.
  • Review of targeted m6A inhibitor strategies.

Main Results:

  • m6A modifications are critical regulators of immune cell homeostasis and anti-tumor immunity.
  • Tumor cell m6A dysregulation influences immune cell activity within the tumor microenvironment.
  • Specific m6A inhibitors show promise for cancer treatment.

Conclusions:

  • m6A plays a significant role in both immune regulation and cancer progression.
  • Targeting m6A pathways offers a potential therapeutic strategy for cancer.
  • Further research into m6A modulators is warranted for clinical application.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
615
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.1K
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
608
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
107
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.9K